The company will institute the measures during the third quarter of 2022 with the financial effects expected to show up from the fourth quarter of the year onward, Babylon said in a news release.
Babylon said it has improved its adjusted EBITDA guidance from $295 million or less to $270 million or less for fiscal 2022, in which its revenue guidance of $1 billion or more will stay the same.
As Becker’s reported, the company has been busy expanding in the U.S. in recent years.
At the Becker's 11th Annual IT + Revenue Cycle Conference: The Future of AI & Digital Health, taking place September 14–17 in Chicago, healthcare executives and digital leaders from across the country will come together to explore how AI, interoperability, cybersecurity, and revenue cycle innovation are transforming care delivery, strengthening financial performance, and driving the next era of digital health. Apply for complimentary registration now.